NCT03165344View on ClinicalTrials.gov

Mixed Gel of Hydrocortisone and Aluminium Phosphate Preventing Endoscopic Submucosal Dissection Postoperative Stenosis for Patients With Large Esophageal Carcinoma

NACompletedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

February 10, 2017

Primary Completion Date

December 31, 2019

Study Completion Date

December 31, 2019

Conditions
Esophageal Stenosis Acquired
Interventions
OTHER

Hydrocortisone sodium succinate mixed with Aluminium Phosphate gel (route of administration)

the test group begin to take hydrocortisone sodium succinate mixed with Aluminium Phosphate gel after 24 hours and gradually reduse the dose.

OTHER

Triamcinolone Acetonide (route of administration)

The control group will get local injection of triamcinolone acetonide in wound during the operation.

OTHER

Prednisone (route of administration)

The control group begin to take oral prednisone after 24 hours and gradually reduse the dose.

Trial Locations (1)

100000

Peking University Third Hospital, Beijing

All Listed Sponsors
lead

Peking University Third Hospital

OTHER

NCT03165344 - Mixed Gel of Hydrocortisone and Aluminium Phosphate Preventing Endoscopic Submucosal Dissection Postoperative Stenosis for Patients With Large Esophageal Carcinoma | Biotech Hunter | Biotech Hunter